The Patent Finder

Somerset Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Somerset Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Somerset Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,239,181Method for preventing and treating peripheral neurophathy by administering selegiline
Lapsed on the fee record
Ended May 29, 2013 · USPTO record
Lapsed on the fee recordEnded May 29, 2013USPTO record
US 6,210,706S (+) Desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
Lapsed on the fee record
Ended Apr 3, 2013 · USPTO record
Lapsed on the fee recordEnded Apr 3, 2013USPTO record
US 6,117,912Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions
Lapsed on the fee record
Ended Sep 12, 2012 · USPTO record
Lapsed on the fee recordEnded Sep 12, 2012USPTO record
US 6,759,053S(+) Desmethylselegiline and Its Use to Treat Adhd
Lapsed on the fee record
Ended Jul 6, 2012 · Low confidence
Lapsed on the fee recordEnded Jul 6, 2012Low confidence
US 6,743,824Method for Preventing and Treating Peripheral Neuropathy by Administering Selegiline
No holder on record
Lapsed on the fee record
Ended Jun 1, 2012 · Medium confidence
Lapsed on the fee recordEnded Jun 1, 2012Medium confidence
US 6,709,664Methods for Treating Photodamaged Skin by Administering Selegiline or Desmethylselegiline
No holder on record
Lapsed on the fee record
Ended Mar 23, 2012 · Low confidence
Lapsed on the fee recordEnded Mar 23, 2012Low confidence
US 6,033,682S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
Lapsed on the fee record
Ended Mar 7, 2012 · USPTO record
Lapsed on the fee recordEnded Mar 7, 2012USPTO record
US 6,699,495Methods for treating multiple sclerosis employing desmethylselegiline
Lapsed on the fee record
Ended Mar 2, 2012 · USPTO record
Lapsed on the fee recordEnded Mar 2, 2012USPTO record
US 6,562,364Desmethylselegiline enantiomers and their use to treat drug withdrawal symptoms
Lapsed on the fee record
Ended May 13, 2011 · USPTO record
Lapsed on the fee recordEnded May 13, 2011USPTO record
US 6,562,365Methods employing R(−)-desmethylselegiline
Lapsed on the fee record
Ended May 13, 2011 · USPTO record
Lapsed on the fee recordEnded May 13, 2011USPTO record
10 of 27 patents shown.
Pro members see all 27.
Pro members: see all 27 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited